Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Quince Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Quince Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Quince Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
$
QNCX
Quince Therapeutics, Inc.
CIK:
0001662774
|
SEC Filings
UNDERWRITING AGREEMENTS
EX-1.2
exhibit12-sx3.htm
2024-12-18T00:00:00Z
EX-1.1
d703513dex11.htm
2019-04-29T00:00:00Z